دورية أكاديمية
Determinants of implanon discontinuation among women who ever used implanon in Shashemene district, west Arsi zone, Southern Ethiopia: unmatched case control study.
| العنوان: | Determinants of implanon discontinuation among women who ever used implanon in Shashemene district, west Arsi zone, Southern Ethiopia: unmatched case control study. |
|---|---|
| المؤلفون: | Lencha B; Department of Public Health, Madda Walabu University, Shashemene, Oromia, Ethiopia. lenibikimule@gmail.com., Daba SG; Center for disease control CDC-Ethiopia, Bishoftu, oromia, Ethiopia., Ahmed JA; Department of Public Health, Madda Walabu University, Shashemene, Oromia, Ethiopia., Washo A; Paradise Valley College, Shashemene, Oromia, Ethiopia., Beressa G; Department of Public Health, Madda Walabu University, Bale Goba, Oromia, Ethiopia., Yalew A; Department of Nursing, Madda Walabu University, Shashemene, Oromia, Ethiopia., Ganfure G; Department of pediatrics, Ambo University, Ambo, Oromia, Ethiopia. |
| المصدر: | Contraception and reproductive medicine [Contracept Reprod Med] 2023 Oct 03; Vol. 8 (1), pp. 46. Date of Electronic Publication: 2023 Oct 03. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: BioMed Central Country of Publication: England NLM ID: 101703414 Publication Model: Electronic Cited Medium: Internet ISSN: 2055-7426 (Electronic) Linking ISSN: 20557426 NLM ISO Abbreviation: Contracept Reprod Med Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: London : BioMed Central, [2016]- |
| مستخلص: | Background: Despite tremendous work has been done on demand creation, capacity building and ensuring the logistics of Implanon; its discontinuation rate remained high in Ethiopia; the prevalence is reported to be 31% in Shashemene District. However, the factors contributing to the high prevalence of early Implanon discontinuation were not well understood in our study setting. Objective: This study aimed to identify the determinants of implanon discontinuation among women who had ever used Implanon in Shashemene District, Southern Ethiopia. Methods: A community-based unmatched case-control study was conducted among randomly selected 264 women (88 cases and 176 controls) in Shashemene District, Southern Ethiopia, from April 12 to May 18, 2021. A systematic random sampling technique was used to select the respondents. Cases were women who discontinued Implanon before 3 years and controls were those who used implanon for 3 full years. A pre-tested, interviewer-administered structured questionnaire was used to collect data. Bivariable and multivariable binary logistic regression analyses were performed to identify determinants of Implanon discontinuation. An odds ratio (OR) with a 95% confidence interval (CI) was used to estimate the strength of the association, and significance was declared at a P value of less than 0.05. Result: The mean age of the respondents was 28.23 (± 5.46) years: 27.27 (± 5.38) years for cases and 28.70 (± 5.5) years for controls. Women with no formal education [AOR = 3.09, 95% CI: (1.20, 8.00)], fewer than four children [AOR = 2.47, 95% CI: (1.20, 5.08)], no history of abortion [AOR = 2.84, 95% CI: (1.25, 6.46)], being new acceptors [AOR = 2.14, 95% CI: (1.02, 4. 49)], being counseled for less than fifteen minutes [AOR = 2.47, 95% CI: (1.29, 4.70)], not discussing it with a partner [AOR = 2.88, 95% CI: (1.42, 5.84)] and experiencing side effects [AOR = 0.35, 95% CI: (0.17, 0.71)] were significantly associated with discontinuation of implanon. Conclusion: Women with no formal education, having less than four children, history of abortion, new acceptors, duration of counseling, discussion with partner, and side effects were determinants of Implanon discontinuation among women. There is a need to ensure adequate pre-implantation counseling and appropriate management of side effects. Furthermore, interventions should target new acceptors and those without formal education. (© 2023. BioMed Central Ltd., part of Springer Nature.) |
| References: | Lofgren M. Implanon NXT PI:Summary of product characteristics: Etonogestrel 68 mg Implant (NXT) (N.V.Organon) RH036 2015: p. 12. FSRH, Faculty of Sexual & Reproductive Healthcare: Progestogen-only Implants Clinical Effectiveness Unit guidance 2014: p. 32. WHO-RHR. WHO statement on Progestogen-only implants. Department of Reproductive Health and Research World Health Organization hrp; 2015. Health WAdo. mplanon NXT®- Etonogestrel Implant Clinical Guidelines: Obstetrics & Gynaecology:WOMEN AND NEWBORN HEALTH SERVICE King Edward Memorial Hospital 2017: p. 6. Weisberg E. Promoting the use of long-acting reversible contraceptives. Austin J Obstet Gynecol. 2014;1(6):6. FDA., IMPLANON™ (etonogestrel implant) 68 mg For Subdermal Use Only: https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021529s004lbl.pdf . 2009. United, Nations, Population Division. D.o.E.a.S.A., (2019). Contraceptive Use by Method 2019: Data Booklet (ST/ESA/SER.A/435) 2019. Thoai D, Ngo et al. 1,., Expanding long-acting and permanent contraceptive use in sub-Saharan Africa to meet FP2020 goals London: Marie Stopes International, 2013. EPHI and ICF. Ethiopian Public Health Institute (EPHI) [Ethiopia] and ICF:Ethiopia Mini demographic and Health Survey 2019: key indicators. Rockville, Maryland, USA. EPHI and ICF.; 2019. Burusie A. Reasons for premature removal of Implanon among users in Arsi zone, Oromia region, Ethiopia, 2013. Sex Disorders: Curr Res. 2015;4(1):1–6. Reproductive System. Habte A, et al. The prevalence of Implanon discontinuation and associated factors among ethiopian women: a systematic review and meta-analysis. Women’s Health. 2022;18:17455057221109222. (PMID: 357625969244932) Tefera Z et al. Factors Associated with Implanon Discontinuation among Women of Reproductive Age in Ethiopia: A Systematic Review and Meta-Analysis International Journal of Reproductive Medicine, 2022. 2022. Fekadu GA et al. Factors associated with early long-acting reversible contraceptives discontinuation in Ethiopia: evidence from the 2016 ethiopian demographic and health survey. Archives of Public Health, 2020: p. 10. Birhane K, Gebreyesus S, Fantahun M. Early discontinuation of implanon and its associated factors among women who ever used implanon in Ofla District, Tigray, Northern Ethiopia. Int J Pharma Sci Res. 2015;6:544–51. Asaye MM, Nigussie TS, Ambaw WM. Early Implanon Discontinuation and Associated Factors among Implanon User Women in Debre Tabor Town, Public Health Facilities, Northwest Ethiopia, 2016. International Journal of Reproductive Medicine, 2018. 2018. Kassie GA, et al. Prevalence of contraceptive implant discontinuation among women who used implant in Ethiopia: systemic review and meta-analysis. SAGE Open Medicine. 2022;10:20503121221135486. (PMID: 10.1177/20503121221135486363857899647267) Tadesse A et al. Determinant of Implanon Discontinuation among Women Who Ever Used Implanon in Diguna Fango District, Wolayita Zone, Southern Ethiopia: A Community Based Case Control Study International Journal of Reproductive Medicine, 2017. 2017: p. 2861207. Weldemariam KT, Gezae KE. and H.T. Abebe Reasons and multilevel factors associated with unscheduled contraceptive use discontinuation in Ethiopia: evidence from Ethiopian demographic and health survey 2016. BMC public health, 2019. 19, 1745 https://doi.org/10.1186/s12889-019-8088-z . Nageso A, Gebretsadik A. Discontinuation rate of Implanon and its associated factors among women who ever used Implanon in Dale District, Southern Ethiopia. BMC Womens Health. 2018;18(1):189. (PMID: 10.1186/s12905-018-0678-x304539316245529) Curtis S, Evens E, Sambisa W. Contraceptive discontinuation and unintended pregnancy: an imperfect relationship. Int Perspect Sex Reproductive Health. 2011;37(2):58–66. (PMID: 10.1363/3705811) Bellizzi S, et al. Reasons for discontinuation of contraception among women with a current unintended pregnancy in 36 low and middle-income countries. Contraception. 2020;101(1):26–33. (PMID: 10.1016/j.contraception.2019.09.00631655068) Mamo K, Desta M. Premature Implanon Discontinuation and Associated Factors Among Implanon User Women in Ambo town, Central Ethiopia, 2018 2018. Mamecha M, Akalewold A, Deresse D. Prevalence and factors associated with early discontinuation rate of Implanon utilization among women who ever used Implanon in Kucha District Gamo Gofa Zone, Southern Ethiopia. BMC Womens Health. 2020;20(1):239. (PMID: 10.1186/s12905-020-01096-1) Dasa TT et al. Factors associated with long-acting family planning service utilization in Ethiopia: a systematic review and meta-analysis. Contracept Reproductive Med. 4(1): p. 14. Dagnew GW et al. Level and timing of Implanon discontinuation and associated factors among women who used Implanon in Andabet District, public health facilities, North-West Ethiopia, 2017. BMC Women Health, 2017. Costenbader E, et al. Factors Associated with delayed contraceptive Implant removal in Ethiopia. Global Health: Science and Practice. 2020;8(3):455. Akilimali PZ, et al. Incidence and determinants of Implanon discontinuation: findings from a prospective cohort study in three health zones in Kinshasa, DRC. PLoS ONE. 2020;15(5):e0232582. (PMID: 10.1371/journal.pone.0232582323922167213683) Thobani R, et al. Factors associated with the discontinuation of modern methods of contraception in the low income areas of Sukh Initiative Karachi: a community-based case control study. PLoS ONE. 2019;14(7):e0218952. (PMID: 10.1371/journal.pone.0218952312690866608957) Jones AE, et al. Follow-up care and 6-month continuation rates for long-acting reversible contraceptives in adolescents and young adults: a retrospective chart review. J Pediatr Adolesc Gynecol. 2020;33(1):39–44. (PMID: 10.1016/j.jpag.2019.09.00331513921) Cohen R, Sheeder J, Teal SB. Predictors of discontinuation of long-acting reversible contraception before 30 months of use by adolescents and young women. J Adolesc Health. 2019;65(2):295–302. (PMID: 10.1016/j.jadohealth.2019.02.02031196778) West Arsi Zone health department., W., Materna and child health annual report, unpublished 2020/21. Yehuala T et al. Determinants of Implanon Discontinuation among Women Who Use Implanon at Bahir Dar Town Health Institutions, Northwest Ethiopia, 2019: A Case-Control Study Evidence-Based Complementary and Alternative Medicine, 2020;9048609. Medhin G. Early Implanon discontinuation rate and its associated factors in health institutions of Mekelle City, Tigray, Ethiopia 2016/17. BMC Res Notes. 2019;12(1):8. (PMID: 10.1186/s13104-018-3992-3) Wondie AG. Implanon Discontinuation Rate and it’s Associated factors in Debre Tabor Town, North Central Ethiopia. Science. 2019;8(2):6–12. Balogun O, et al. Implanon sub-dermal implant: an emerging method of contraception in Ilorin, Nigeria. J Med Biomedical Sci. 2014;3(1):1–5. (PMID: 10.4314/jmbs.v3i1.1) Tolesa B, Alem G, Papelon T. Factors associated with contraceptive discontinuation in Agarfa district, Bale Zone, south east Ethiopia. Volume 5. Epidemiology: Open Access; 2015. 1. Dagnew GW et al. Level and timing of Implanon discontinuation and associated factors among women who used Implanon in Andabet District, public health facilities, North-West Ethiopia BioMed research international, 2021. Mrwebi KP, et al. Reasons for discontinuation of Implanon among users in Buffalo City Metropolitan Municipality, South Africa: a cross-sectional study. Afr J Reprod Health. 2018;22(1):113–9. (PMID: 29777648) Aziz MM, El-Gazzar AF, Elgibaly O. Factors associated with first-year discontinuation of Implanon in upper Egypt: clients’ and providers’ perspectives BMJ sexual & reproductive health, 2018;44(4):260–266. Siyoum M et al. Implanon discontinuation rate and associated factors among women who ever used Implanon in the last three years in Debre Markos town, Northwest Ethiopia, 2016, cross sectional study. ARC Journal of Public Health and Community of Medicine, 2017. 2: p. 8–16. |
| فهرسة مساهمة: | Keywords: Ethiopia; Implanon; Implanon discontinuation; Women |
| تواريخ الأحداث: | Date Created: 20231003 Latest Revision: 20231121 |
| رمز التحديث: | 20240628 |
| مُعرف محوري في PubMed: | PMC10548583 |
| DOI: | 10.1186/s40834-023-00248-6 |
| PMID: | 37789494 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder كن أول من يترك تعليقا!